These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9561163)

  • 1. Heterogeneous distribution of COX-2 over-expression in human colon carcinoma cells.
    Berg J; Christoph T; Bodenteich A; Towart R
    Adv Exp Med Biol; 1997; 433():327-30. PubMed ID: 9561163
    [No Abstract]   [Full Text] [Related]  

  • 2. Fenretinide inhibits phorbol ester-induced cyclooxygenase-2 expression in human colon adenocarcinoma cells.
    Aliprandis ET; Merritt G; Prada F; Rigas B; Kashfi K
    Biochem Soc Trans; 1997 Aug; 25(3):457S. PubMed ID: 9388681
    [No Abstract]   [Full Text] [Related]  

  • 3. Nitric oxide induces cyclooxygenase expression and inhibits cell growth in colon cancer cell lines.
    Liu Q; Chan ST; Mahendran R
    Carcinogenesis; 2003 Apr; 24(4):637-42. PubMed ID: 12727790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of group X secretory phospholipase A(2) in cyclooxygenase-2-dependent PGE(2) formation during colon tumorigenesis.
    Morioka Y; Ikeda M; Saiga A; Fujii N; Ishimoto Y; Arita H; Hanasaki K
    FEBS Lett; 2000 Dec; 487(2):262-6. PubMed ID: 11150521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colonic luminal contents (faecal water) induce COX-2.
    Glinghammar B
    IARC Sci Publ; 2002; 156():431-3. PubMed ID: 12484230
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of nonsteroidal antiinflammatory drugs on colonic lipoxygenase and cyclooxygenase activities from patients with colonic neoplasia].
    Di Girolamo G; Franchi A; De Los Santos AR; Martí ML; Farina M; Fernández de Gimeno MA
    Medicina (B Aires); 2001; 61(5 Pt 1):566-72. PubMed ID: 11721323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PHGPx overexpression induces an increase in COX-2 activity in colon carcinoma cells.
    Barrière G; Rabinovitch-Chable H; Cook-Moreau J; Faucher K; Rigaud M; Sturtz F
    Anticancer Res; 2004; 24(3a):1387-92. PubMed ID: 15274299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of cyclooxygenase-2 in macrophages of human colonic adenoma.
    Bamba H; Ota S; Kato A; Adachi A; Itoyama S; Matsuzaki F
    Int J Cancer; 1999 Nov; 83(4):470-5. PubMed ID: 10508481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention.
    Reddy BS; Hirose Y; Cohen LA; Simi B; Cooma I; Rao CV
    Cancer Res; 2000 Sep; 60(17):4792-7. PubMed ID: 10987288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent modulation of apoptosis and cyclooxygenase-2 expression in human 1547 osteosarcoma cells by NS-398, a selective cyclooxygenase-2 inhibitor.
    Moalic S; Liagre B; Le Bail JC; Beneytout JL
    Int J Oncol; 2001 Mar; 18(3):533-40. PubMed ID: 11179483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenomethionine inhibits growth and suppresses cyclooxygenase-2 (COX-2) protein expression in human colon cancer cell lines.
    Baines A; Taylor-Parker M; Goulet AC; Renaud C; Gerner EW; Nelson MA
    Cancer Biol Ther; 2002; 1(4):370-4. PubMed ID: 12432249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
    Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus self-improvement through inflammation: no pain, no gain.
    Mocarski ES
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3362-4. PubMed ID: 11904398
    [No Abstract]   [Full Text] [Related]  

  • 14. [Colon cancer and COX-2].
    Ota S; Bamba H; Imai Y; Arai S; Fujiwara K
    Nihon Shokakibyo Gakkai Zasshi; 2002 Mar; 99(3):253-63. PubMed ID: 11925862
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal cancer cells.
    Li M; Song S; Lippman SM; Zhang XK; Liu X; Lotan R; Xu XC
    Oncogene; 2002 Jan; 21(3):411-8. PubMed ID: 11821953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas.
    Okami J; Yamamoto H; Fujiwara Y; Tsujie M; Kondo M; Noura S; Oshima S; Nagano H; Dono K; Umeshita K; Ishikawa O; Sakon M; Matsuura N; Nakamori S; Monden M
    Clin Cancer Res; 1999 Aug; 5(8):2018-24. PubMed ID: 10473081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic receptor up-regulates COX-2 expression and prostaglandin E(2) production in colon cancer cells.
    Yang WL; Frucht H
    Carcinogenesis; 2000 Oct; 21(10):1789-93. PubMed ID: 11023534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyclooxygenases, and the cell cycle. Their interactions in colon cancer.
    Rigas B; Shiff SJ
    Adv Exp Med Biol; 1999; 470():119-26. PubMed ID: 10709681
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-kappa B activation.
    Kojima M; Morisaki T; Izuhara K; Uchiyama A; Matsunari Y; Katano M; Tanaka M
    Oncogene; 2000 Feb; 19(9):1225-31. PubMed ID: 10713711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: cyclooxygenase--a target for colon cancer prevention.
    Dubois RN
    Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():64-7. PubMed ID: 10807405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.